Glyn Parkin active positions
| Companies | Position | Start | End |
|---|---|---|---|
DiogenX SAS
 DiogenX SAS BiotechnologyHealth Technology DiogenX SAS engages in the discovery and development of biologics therapeutics options of Diabetic patients. It operates in Diabetes preclinical stage business segment. The company was founded by Benjamin Charles, Patrick Collombat and Jean Pascal Tranié on December 24, 2019 and is headquartered in Marseille, France. | Chairman | - | - |
| Independent Dir/Board Member | - | - |
Career history of Glyn Parkin
Former positions of Glyn Parkin
| Companies | Position | Start | End |
|---|---|---|---|
| THE MEDICINES COMPANY | Chief Operating Officer | - | 23/07/2009 |
| Corporate Officer/Principal | 23/07/2009 | - |
Statistics
International
| United States | 2 |
| France | 2 |
Operational
| Chief Operating Officer | 1 |
| Corporate Officer/Principal | 1 |
| Chairman | 1 |
Sectoral
| Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
The Medicines Co.
 The Medicines Co. Pharmaceuticals: MajorHealth Technology The Medicines Co. is a biopharmaceutical company, which focuses on saving lives, alleviating suffering and contributing to the economics of healthcare by focusing on acute and intensive care hospitals worldwide. The firm markets its brands Angiomax, Cleviprex, injectable emulsion, Ionsys, Kengreal, Minocin for injection, and Orbactiv. The company was founded by Clive A. Meanwell, Helmut Giersiefen, John W. Villiger and T. Scott Johnson on July 31, 1996 and is headquartered in Parsippany, NJ. | Health Technology |
DiogenX SAS
DiogenX SAS BiotechnologyHealth Technology DiogenX SAS engages in the discovery and development of biologics therapeutics options of Diabetic patients. It operates in Diabetes preclinical stage business segment. The company was founded by Benjamin Charles, Patrick Collombat and Jean Pascal Tranié on December 24, 2019 and is headquartered in Marseille, France. | Health Technology |
- Stock Market
- Insiders
- Glyn Parkin
- Experience
